10-QPeriod: Q2 FY2025

UNITEDHEALTH GROUP INC Quarterly Report for Q2 Ended Jun 30, 2025

Filed August 11, 2025For Securities:UNH

Summary

UnitedHealth Group (UNH) reported solid top-line growth in its second quarter of 2025, with total revenues increasing by 13% year-over-year to $111.6 billion. This growth was driven by a strong performance in UnitedHealthcare, particularly Medicare Advantage and commercial offerings, which saw a 17% revenue increase and a 1.03 million increase in people served. Optum's revenue also grew by 6%, primarily fueled by Optum Rx. Despite revenue growth, earnings from operations saw a significant decline of 35% to $5.2 billion, impacted by elevated medical cost trends, particularly within Medicare Advantage and the individual exchange offerings. This was further compounded by the ongoing effects of the Inflation Reduction Act (IRA) on Medicare Part D, and increased unit costs and care activity. The company continues to manage these pressures through cost management initiatives and strategic pricing adjustments.

Financial Highlights

54 data points
Beta

Revenue

$111.62B

88.3% Gross Margin

Net Income

$3.41B

3.1% Net Margin

EPS (Diluted)

$3.74

Total Assets

$308.57B

Cash & Equivalents

$28.60B

Free Cash Flow

$6.30B

Financial Statements
Beta
Revenue$111.62B
Cost of Revenue$13.02B
Gross Profit$98.60B
SG&A Expenses$13.78B
Operating Expenses$106.47B
Operating Income$5.15B
Interest Expense$1.03B
Net Income$3.41B
EPS (Basic)$3.76
EPS (Diluted)$3.74
Shares Outstanding (Basic)907.00M
Shares Outstanding (Diluted)910.00M

Key Highlights

  • 1Total revenues grew 13% to $111.6 billion, driven by strong performances across UnitedHealthcare and Optum Rx.
  • 2UnitedHealthcare revenue increased 17% to $86.1 billion, serving 1.03 million more people, primarily in Medicare Advantage and commercial segments.
  • 3Optum revenue grew 6% to $67.2 billion, with Optum Rx showing significant growth.
  • 4Earnings from operations decreased by 35% to $5.2 billion, largely due to elevated medical cost trends and the impact of the Inflation Reduction Act on Medicare Part D.
  • 5Medical costs rose 20% year-over-year, impacting the medical care ratio (MCR) which increased to 89.4% from 85.1% in the prior year's quarter.
  • 6The company repurchased approximately 6.1 million shares of common stock for $2.5 billion during the quarter.
  • 7UnitedHealth Group's cash flow from operations was robust, reaching $12.6 billion for the six months ended June 30, 2025.

Frequently Asked Questions

The primary drivers for the increase in medical costs are the Inflation Reduction Act (IRA) impacting Medicare Part D plans, elevated overall medical cost trends (including increased unit costs and care activity), and growth in the number of individuals served in Medicare Advantage and those with higher acuity needs.

UnitedHealthcare saw a significant 17% revenue increase, but its earnings from operations decreased by 48% due to higher medical costs. Optum Health's revenue declined 7%, and its earnings from operations dropped 67%, also impacted by funding reductions and cost trends. Optum Insight's revenue grew 6% with a substantial 83% increase in earnings from operations, benefiting from reduced disruptions related to the Change Healthcare cyberattack. Optum Rx reported a 19% revenue increase and a 2% rise in earnings from operations, driven by higher script volumes and operational efficiencies.

The company notes ongoing pressure on Medicare Advantage funding, with industry base rates historically below forward medical cost trends. Significant revisions to the risk adjustment model are expected to result in reduced funding and potentially fewer benefits for beneficiaries, particularly those with complex health needs. The company is actively managing these pressures through cost management, network adjustments, benefit design changes, and careful selection of markets for offering plans.

Yes, during the six months ended June 30, 2025, UnitedHealth Group repurchased approximately 12.1 million shares of common stock. The company also announced an increase in its quarterly cash dividend to an annual rate of $8.84 per share, up from $8.40 per share.